Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
7.14
-0.56 (-7.27%)
Apr 29, 2026, 1:01 PM EDT - Market open
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $337.25 million as of April 29, 2026. Its market cap has increased by 177.88% in one year.
Market Cap
337.25M
Enterprise Value
251.35M
1-Year Change
177.88%
Ranking
Category
Stock Price
$7.14
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $337.25M, a decrease of -37.36%. That is a compound annual growth rate of -7.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 363.70M | 26.64% |
| Dec 31, 2025 | 287.18M | -11.59% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| X4 Pharmaceuticals | 388.23M |
| Autolus Therapeutics | 387.24M |
| Puma Biotechnology | 383.61M |
| Opus Genetics | 377.72M |
| YD Bio | 374.10M |
| Armata Pharmaceuticals | 366.33M |
| Monopar Therapeutics | 361.38M |
| Ovid Therapeutics | 353.42M |